NSRX
NSRX
AMEX · Pharmaceuticals

Nasus Pharma Ltd

$2.60
+0.11 (+4.42%)
As of Mar 25, 4:51 PM ET ·
Financial Highlights (FY 2025)
Revenue
16.90M
Net Income
2.99M
Gross Margin
58.3%
Profit Margin
17.7%
Rev Growth
+19.1%
D/E Ratio
0.36
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 58.3% 58.3% 58.3%
Operating Margin 24.2% 24.0% 24.0%
Profit Margin 17.7% 18.5% 20.3%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 16.90M 15.57M 15.33M
Gross Profit 9.84M 9.07M 8.93M
Operating Income 4.08M 3.74M 3.68M
Net Income 2.99M 2.88M 3.11M
Gross Margin 58.3% 58.3% 58.3%
Operating Margin 24.2% 24.0% 24.0%
Profit Margin 17.7% 18.5% 20.3%
Rev Growth +19.1% +9.8% -6.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 8.79M 9.10M 10.20M
Total Equity 24.63M 26.89M 27.54M
D/E Ratio 0.36 0.34 0.37
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 3.97M 4.34M 3.61M
Free Cash Flow 3.54M 3.27M 3.55M